Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 AUD | 0.00% | +3.33% | -22.50% |
Apr. 16 | Amplia Therapeutics to Raise AU$4.3 Million for Cancer Trials, Drug Capsule Manufacturing | MT |
Mar. 27 | Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-22.50% | 7.81M | |
-1.30% | 104B | |
+4.39% | 97.47B | |
+5.85% | 22.25B | |
-13.61% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-11.52% | 16.36B | |
+8.71% | 14.39B | |
+41.10% | 12.37B |
- Stock Market
- Equities
- ATX Stock
- News Amplia Therapeutics Limited
- Amplia Therapeutics Gets Nod to Name Drug AMP945 Narmafotinib